What changed in Elevance Health, Inc.'s latest annual report
In the year ended 31 Dec 2025, Elevance Health, Inc.'s revenue rose 12.5% to USD 199.12bn, from USD 177.01bn; net income fell 5.3% to USD 5.66bn, from USD 5.98bn; cash and cash equivalents rose 14.5% to USD 9.49bn, from USD 8.29bn.
Year ended 31 Dec 2025. Source: 10-K filed 6 Feb 2026, read it on SEC EDGAR.
USD 177.01bn to USD 199.13bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 177.01bn | 199.13bn | Up 12.5% |
| Net income | 5.98bn | 5.66bn | Down 5.3% |
| Total assets | 116.89bn | 121.49bn | Up 3.9% |
| Total liabilities | 75.46bn | 77.47bn | Up 2.7% |
| Long-term debt | 29.22bn | 30.80bn | Up 5.4% |
| Cash and cash equivalents | 8.29bn | 9.49bn | Up 14.5% |
| Shareholders' equity | 41.31bn | 43.88bn | Up 6.2% |
Questions people ask
Did Elevance Health, Inc.'s revenue grow last year?
Revenue grew 12.5%, from USD 177.01bn to USD 199.13bn in the year ended 31 Dec 2025.
Is Elevance Health, Inc. profitable?
Yes. Net income was USD 5.66bn in the year ended 31 Dec 2025. The year before: USD 5.98bn.
How much cash and debt does Elevance Health, Inc. have?
At its latest year end (31 Dec 2025), Elevance Health, Inc. reported cash and cash equivalents of USD 9.49bn and long-term debt of USD 30.80bn.
Where do these numbers come from?
From Elevance Health, Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Elevance Health, Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Hospital & Medical Service Plans companies
- UnitedHealth Group IncorporatedNet income down 16.3%
- The Cigna GroupNet income up 73.5%
- Humana IncCash and cash equivalents up 89.1%
- Centene CorporationCash and cash equivalents up 27.2%
- Molina Healthcare, Inc.Net income down 60%
- Oscar Health, Inc.Cash and cash equivalents up 81.7%